Zimbabwe has declined a major American healthcare agreement worth 367 million US dollars (272 million pounds) over five years due to Washington's request for confidential data.
The decision became public following a government memo from December was disclosed, which showed President Emmerson Mnangagwa felt the arrangement was "unbalanced".
A government representative has since explained that the US was demanding access to biological samples for research and commercial purposes but refused to share the resulting advantages from any future vaccines.
"We will now turn to the difficult and regrettable process of ending our health assistance in Zimbabwe," said American envoy to Zimbabwe Pamela Tremont publicly.
The US Embassy said the US had provided more than $1.9bn in health funding to Zimbabwe over the last two decades.
A medical body in Zimbabwe has called for continued negotiations to secure a agreement agreeable to both sides so the nation's critical HIV programme can proceed.
Wider Background
This development follows a comparable situation in neighbouring Kenya, where a court halted a similar deal with the US after legal challenges were filed about the security of citizens' health data.
Since resuming the presidency recently, US President Donald Trump has drastically cut overseas assistance and closed the US Agency for International Development (USAID).
The agency had managed assistance for the American government, but Trump claimed its spending was "wasteful" and his government was pursuing direct bilateral agreements to enhance transparency and accountability.
According to statements, 16 African countries have to date signed similar health pacts, constituting over $18.3bn in committed funds.
Specifics of the Declined Agreement
The funds for Zimbabwe would have supported "tackling HIV/Aids, tuberculosis, malaria, healthcare for mothers and children, and preparing for epidemics".
"We are confident this partnership could have provided extraordinary benefits for Zimbabwean communities, especially the 1.2 million presently receiving antiretroviral therapy via American-funded programmes," Tremont added.
However, government spokesperson Nick Mangwana argued the arrangement was "unfair".
"The proposal required Zimbabwe to surrender its biological resources and data over an extended period, with no equivalent assurance of access to any medical innovations – such as new medicines or tests – that could result from that provided information," he stated.
"Put simply, our nation would supply the basic resources for scientific discovery with no assurance that the resulting innovations would be accessible to our citizens should a future disease outbreak emerge."
Sovereignty and Global Health
Mangwana further pointed out that the American exit from the World Health Organization (WHO) and its push of bilateral health agreements were disrupting systems already established through the global organization.
The spokesperson cited its Pathogen Access and Benefit Sharing framework designed to deal with future global health emergencies.
"This mechanism is intended to ensure that when a nation provides its samples, the benefits – including vaccines and treatments – are shared equitably, not commercialised exclusively by those with the funds to create them."
The government's concerns regarding the US deal "should not be misconstrued as opposition to America," Mangwana stressed.
"We welcome further dialogue with our US partners on how future collaboration might be structured in a manner that honours the sovereignty and interests of each country."
Health Experts Reaction
A leading public health body said it acknowledged the government's concerns, but recommended that talks must proceed given that a large portion of the nation's Aids initiatives relied on international support.
"In cases where specific concerns arise, including those relating to data governance or implementation frameworks, these can frequently be addressed through detailed discussion and negotiated safeguards," it said.
The halted deal underscores the ongoing tensions between receiving crucial international aid and safeguarding local interests in an increasingly interconnected world.